Yan Ning
Impact in
-
- Protease and Inhibitor Mechanisms
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 3
- Cancer-related gene regulation 2
- Wnt/β-catenin signaling in development and cancer 2
- RNA Research and Splicing 2
-
- Cancer Genomics and Diagnostics 4
- Cancer-related molecular mechanisms research 3
- Cancer, Lipids, and Metabolism 2
- Co-authors
- David A. Fishman (1 shared paper)Karen D. Cowden Dahl (1 shared paper)M. Sharon Stack (1 shared paper)Laurie G. Hudson (1 shared paper)Brian P. Adley (1 shared paper)Jaime Symowicz (1 shared paper)Heinz‐Josef Lenz (11 shared papers)Dongyun Yang (9 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Pharmacogenetics and Genomics (1 paper)Cancers (1 paper)Aging (1 paper)Journal of Cellular and Molecular Medicine (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Yan Ning
20 papers receiving 409 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 92
- Developmental Biology 10
- Oncology 112
- Pulmonary and Respiratory Medicine 89
- Immunology and Allergy 15
Countries citing papers authored by Yan Ning
This map shows the geographic impact of Yan Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ning more than expected).
Fields of papers citing papers by Yan Ning
This network shows the impact of papers produced by Yan Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ning. The network helps show where Yan Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 166 | |
| 2 | 2008 | 152 | |
| 3 | 2018 | 18 | |
| 4 | 2014 | 14 | |
| 5 | 2022 | 12 | |
| 6 | 2021 | 10 | |
| 7 | IMP3 is upregulated in primary ovarian mucinous carcinoma and promotes tumor progression. | 2017 | 9 |
| 8 | 2018 | 8 | |
| 9 | 2018 | 6 | |
| 10 | 2018 | 6 | |
| 11 | 2021 | 4 | |
| 12 | 2020 | 4 | |
| 13 | 2020 | 4 | |
| 14 | 2013 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2015 | 1 | |
| 17 | 2012 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2015 | 1 | |
| 20 | 2016 | 1 |
About Yan Ning
Yan Ning is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 20 papers that have together received 420 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (3 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer-related gene regulation (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (92 citations), Developmental Biology (10 citations), Oncology (112 citations), Pulmonary and Respiratory Medicine (89 citations) and Immunology and Allergy (15 citations). Yan Ning has collaborated with scholars based in United States, China and Germany. Frequent co-authors include David A. Fishman, Karen D. Cowden Dahl, M. Sharon Stack, Laurie G. Hudson, Brian P. Adley, Jaime Symowicz, Heinz‐Josef Lenz, Dongyun Yang, Georg Lurje and Kayo Togawa. Their work appears in journals such as Journal of Clinical Oncology, Pharmacogenetics and Genomics, Cancers, Aging and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.